Evoke plc (LON:EVOK – Get Free Report) was down 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on EVOK. Jefferies Financial Group reissued a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th. Berenberg Bank cut their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a report on Wednesday, December 4th.
Read Our Latest Stock Analysis on EVOK
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last released its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Research analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Activity
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were bought at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Insiders own 27.00% of the company’s stock.
About Evoke
See Also
- Five stocks we like better than Evoke
- Dividend Payout Ratio Calculator
- MarketBeat Week in Review – 03/24 – 03/28
- Overbought Stocks Explained: Should You Trade Them?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Stock Market Upgrades: What Are They?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.